Chongqing Sintaho Pharmaceutical Co., Ltd.

Chongqing Sintaho Pharmaceutical Co., Ltd. (China) holds 13 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 12 active ingredients, holds 1 active Type IV (excipient) Drug Master File and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Chongqing Sintaho Pharmaceutical Co., Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/chongqing-sintaho-pharmaceutical-co-ltd

Overview

Chongqing Sintaho Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Chongqing, China.

Active ingredients with DMF or CEP filings

Substances for which Chongqing Sintaho Pharmaceutical Co., Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Chongqing Sintaho Pharmaceutical Co., Ltd. holds 13 active (13 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ORFORGLIPRON INTERMEDIATE IIIActive2026-09-24
  • ORFORGLIPRON CALCIUMActive2026-07-10
  • IXAZOMIB CITRATEActive2026-07-09
  • TRABECTEDINActive2026-05-15
  • LURBINECTEDINActive2026-03-31
  • PEMETREXED DISODIUM HEPTAHYDRATEActive2025-11-05
  • SEMAGLUTIDEActive2025-06-23
  • CARFILZOMIBActive2025-03-11
  • TIRBANIBULINActive2024-03-19
  • ERIBULIN MESYLATEActive2023-01-31
  • DOCETAXELActive2022-06-27
  • PACLITAXEL (SEMI-SYNTHETIC)Active2021-11-18
  • AZACITIDINE USPActive2014-03-12

Excipient Drug Master Files

Chongqing Sintaho Pharmaceutical Co., Ltd. holds 1 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Chongqing Sintaho Pharmaceutical Co., Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Chongqing Sintaho Pharmaceutical Co., Ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Chongqing Sintaho Pharmaceutical Co., Ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.